Seo Jeong Kyun, Ryu Ji Kon, Lee Sang Hyub, Park Joo Kyung, Yang Ki Young, Kim Yong-Tae, Yoon Yong Bum, Lee Hae Won, Yi Nam-Joon, Suh Kyung Suk
Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Liver Transpl. 2009 Apr;15(4):369-80. doi: 10.1002/lt.21700.
Endoscopic intervention is considered to be the primary treatment for biliary stricture after adult living donor liver transplantation (LDLT) with duct-to-duct biliary reconstruction. The aim of this study was to investigate the risk factors of biliary stricture and the clinical outcomes and predictors of failure after endoscopic retrograde cholangiography with balloon dilation (ERC-D). We enrolled 239 adult patients who underwent LDLT between 2000 and 2006. Sixty-eight patients (28.4%) developed biliary stricture. Twenty-nine patients with anastomotic biliary stricture were treated with ERC-D and stenting. We retrospectively analyzed the risk factors of biliary stricture and the clinical outcomes of ERC-D. The median follow-up period was 31 months. The risk factors of biliary stricture on multiple logistic regression analysis were a graft with multiple bile ducts, a previous history of bile leakage, and hepatic artery stenosis. The overall success rate of ERC-D was 64.5%. On simple logistic regression, the failure of primary ERC-D was associated with late biliary stricture over 24 weeks and more than 8 weeks between a 2-fold increase of serum alkaline phosphatase from the stable level and ERC-D, even though these were not statistically significant on multiple logistic regression. The relapse rate of stricture after successful ERC-D was 30%. The duration of stenting in the recurrence group was shorter than that in the nonrecurrence group (11.8 +/- 5.03 versus 29.0 +/- 11.6 weeks, P = 0.004). ERC-D is effective for the management of anastomotic biliary stricture. However, the failure rate of primary ERC-D may be high in patients with late onset and delayed diagnosis of biliary stricture. The recurrence seems to occur frequently in patients with a short duration of stenting.
对于采用胆管对胆管方式进行胆肠重建的成人活体肝移植(LDLT)术后胆管狭窄,内镜介入被视为主要治疗方法。本研究旨在探讨胆管狭窄的危险因素以及内镜逆行胆管造影联合球囊扩张术(ERC-D)后治疗失败的临床结局和预测因素。我们纳入了2000年至2006年间接受LDLT的239例成年患者。68例患者(28.4%)发生了胆管狭窄。29例吻合口胆管狭窄患者接受了ERC-D及支架置入治疗。我们回顾性分析了胆管狭窄的危险因素以及ERC-D的临床结局。中位随访期为31个月。多因素logistic回归分析显示,胆管狭窄的危险因素包括有多根胆管的移植物、既往胆漏史和肝动脉狭窄。ERC-D的总体成功率为64.5%。单因素logistic分析显示,初次ERC-D治疗失败与术后24周以上的晚期胆管狭窄以及血清碱性磷酸酶从稳定水平升高2倍至进行ERC-D的时间间隔超过8周有关,尽管在多因素logistic回归分析中这些因素无统计学意义。ERC-D成功后狭窄复发率为30%。复发组的支架置入时间短于未复发组(11.8±5.03对29.0±11.6周,P = 0.004)。ERC-D对吻合口胆管狭窄的治疗有效。然而,对于胆管狭窄发病较晚且诊断延迟的患者,初次ERC-D的失败率可能较高。支架置入时间短的患者似乎更容易复发。